Mesenchymal stem cell extract and its use
First Claim
1. A method for at least one of promoting the expression of hyaluronic acid (HA), elastin, collagen and/or reticulin in the skin, stimulating cell proliferation at the administered region, stimulating cells at the administered region to secrete a trophic factor, and stimulating endogenous hematopoietic progenitor cells (HPC) to gather and proliferate at the administered region in a subject, comprising administering to the subject an effective amount of a mesenchymal stem cell extract, wherein the mesenchymal stern cell extract is a supernatant comprising bone morphogenetic protein-7 (BMP-7), stromal cell-derived factor-1 (SDF- 1), vascular endothelial growth factor (VEGF), C-X-C chemokine receptor type-4 (CXCR4), brain-derived neurotrophic factor (BDNF) and interleukin-17 (IL-17), and the supernatant is provided by the following steps:
- (1) mixing mesenchymal stem cells separated from an animal fat tissue with a proteolysis buffer containing NP40 lysis buffer, phenylmethanesulfonyl fluoride (PMSF), a protease inhibitor, p-glycerol phosphate and Na3V04, to lyse the cells and provide a cell lysate; and
b(2) centrifuging the cell lysate at a temperature of no more than 4°
C. to collect the supernatant.
1 Assignment
0 Petitions
Accused Products
Abstract
A mesenchymal stem cell extract and its use are provided, wherein the mesenchymal stem cell extract comprises a trophic factor(s), such as bone morphogenetic protein-7 (BMP-7), stromal cell-derived factor-1 (SDF-1), vascular endothelial growth factor (VEGF), C-X-C chemokine receptor type-4 (CXCR4), brain-derived neurotrophic factor (BDNF), and/or interleukin-17 (IL-17), and wherein the extract is especially suitable for repairing skin aging.
5 Citations
10 Claims
-
1. A method for at least one of promoting the expression of hyaluronic acid (HA), elastin, collagen and/or reticulin in the skin, stimulating cell proliferation at the administered region, stimulating cells at the administered region to secrete a trophic factor, and stimulating endogenous hematopoietic progenitor cells (HPC) to gather and proliferate at the administered region in a subject, comprising administering to the subject an effective amount of a mesenchymal stem cell extract, wherein the mesenchymal stern cell extract is a supernatant comprising bone morphogenetic protein-7 (BMP-7), stromal cell-derived factor-1 (SDF- 1), vascular endothelial growth factor (VEGF), C-X-C chemokine receptor type-4 (CXCR4), brain-derived neurotrophic factor (BDNF) and interleukin-17 (IL-17), and the supernatant is provided by the following steps:
-
(1) mixing mesenchymal stem cells separated from an animal fat tissue with a proteolysis buffer containing NP40 lysis buffer, phenylmethanesulfonyl fluoride (PMSF), a protease inhibitor, p-glycerol phosphate and Na3V04, to lyse the cells and provide a cell lysate; and b(2) centrifuging the cell lysate at a temperature of no more than 4°
C. to collect the supernatant. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10)
-
Specification